ECSS
EW icon

Eurizon Capital SGR SpA’s Edwards Lifesciences EW Stock Holding History

Eurizon Capital SGR SpA’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17M Buy
187,556
+34,019
+22% +$2.85M 0.05% 260
2026
Q1 		$12.3M Sell
153,537
-6,741
-4% -$556K 0.04% 299
2025
Q4 		$13.7M Buy
+160,278
New +$13.2M 0.04% 249

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Eurizon Capital SGR SpA's EW Position: Q2 2026 in Review

Eurizon Capital SGR SpA increased its Edwards Lifesciences (EW) stake by 22% in Q2 2026, buying an estimated $2.85M and bringing the position to 187,556 shares worth $17M. The position accounts for 0.05% of the portfolio, ranked #260.

Eurizon Capital SGR SpA first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Eurizon Capital SGR SpA held 187,556 shares of Edwards Lifesciences worth $17M as of Q2 2026.
  • Eurizon Capital SGR SpA bought 34,019 Edwards Lifesciences shares in Q2 2026, an estimated $2.85M.
  • Edwards Lifesciences made up 0.05% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #260 holding.
  • Eurizon Capital SGR SpA first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.